Table 4.
Pharmacokinetic parameters | Cohort 2 dolutegravir + telaprevir (n = 15) | Telaprevir alone§ |
---|---|---|
AUC0–τ (μg h ml−1) | 19.2 (19) | 22.3 |
Cmax (μg ml−1) | 3.21 (17) | 3.51 |
Cτ (μg ml−1) | 1.75 (26) | – |
Cmin (μg ml−1) | 1.72 (25) | 2.03 |
t1/2 (h)† | 5.14 (27) | – |
Tmax (h)‡ | 3.00 (2.0, 4.0) | – |
Abbreviations are as for Table 3.
Geometric mean (between subject coefficient of variation, %CVb).
n = 10.
Presented as median (range).
Telaprevir package insert, 2013.